Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma
Abstract Background Herein, we investigate the relationship between pancreatic stem cell markers (PCSC markers), CD44, and epithelial-specific antigen (ESA), tumor stroma, and the impact on recurrence outcomes in pancreatic ductal adenocarcinoma (PDAC) patients. Methods PDAC patients who underwent s...
Main Authors: | Gokce Askan, Ibrahim Halil. Sahin, Joanne F. Chou, Aslihan Yavas, Marinela Capanu, Christine A. Iacobuzio-Donahue, Olca Basturk, Eileen M. O’Reilly |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08123-w |
Similar Items
-
Pancreatic cancer microenvironment: a current dilemma
by: Burak Uzunparmak, et al.
Published: (2019-01-01) -
Expression of Calretinin, Marker of Mesothelial Differentiation, in Pancreatic Ductal Adenocarcinoma: A Potential Diagnostic Pitfall
by: Gokce ASKAN, et al.
Published: (2021-05-01) -
Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
by: Norihiro Sato, et al.
Published: (2016-03-01) -
Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic Adenocarcinoma
by: Daniel H. Ahn, et al.
Published: (2018-06-01) -
Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma
by: Dajia Liu, et al.
Published: (2020-10-01)